Literature DB >> 1928211

Oxidant-antioxidant balance: some observations from studies of ischemia-reperfusion in isolated perfused rat hearts.

J E Repine1.   

Abstract

Alteration in oxidant-antioxidant balance is a key feature of many common vascular diseases. Using an isolated perfused heart model, we found that (a) xanthine oxidase-derived oxygen radicals contributed to ischemia-reperfusion injury; (b) addition of antioxidants within or outside erythrocytes decreased injury following ischemia-reperfusion; (c) endotoxin pretreatment increased myocardial catalase activity and decreased injury following ischemia-reperfusion; (d) interleukin pretreatment increased myocardial glucose-6-phosphate activity and decreased ischemia-reperfusion injury, and (e) neutrophils mediated tolerance to a subsequent oxidative stress by causing a small oxidant stress that in turn increased antioxidant protection mechanisms.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1928211     DOI: 10.1016/0002-9343(91)90283-4

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  4 in total

1.  Oxidative stress adaptation improves postischemic ventricular recovery.

Authors:  N Maulik; M Watanabe; D T Engelman; R M Engelman; D K Das
Journal:  Mol Cell Biochem       Date:  1995-03-09       Impact factor: 3.396

2.  Resveratrol: French paradox revisited.

Authors:  Betul Catalgol; Saime Batirel; Yavuz Taga; Nesrin Kartal Ozer
Journal:  Front Pharmacol       Date:  2012-07-17       Impact factor: 5.810

3.  Cytochrome P-450-catalyzed reactive oxygen species production mediates the (-)schisandrin B-induced glutathione and heat shock responses in H9c2 cardiomyocytes.

Authors:  Na Chen; Po Yee Chiu; Hoi Yan Leung; Kam Ming Ko
Journal:  Indian J Pharmacol       Date:  2012-03       Impact factor: 1.200

Review 4.  Interleukin-1-mediated acute lung injury and tolerance to oxidative injury.

Authors:  J E Repine
Journal:  Environ Health Perspect       Date:  1994-12       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.